Viking Therapeutics, Inc. (VKTX) shares surged 11.7% in pre-market trading after the company announced plans to advance its oral obesity treatment drug to late-stage trials.
Show original
This positive market response highlights investors' confidence in the company's progress in the field of metabolic disease treatment.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreShareholders of Blue Owl Capital Corporation (OBDC) who choose to participate in the tender offer initiated by Cox and Saba will receive a per-share consideration significantly lower than the current net asset value (NAV) of the investment company.
According to the latest disclosed information, shareholders of the OBDC II project under Blue Owl Capital are expected to receive significant cash returns in 2026.
Crypto prices
More
Bitcoin
BTC
$68,109.41
-4.01%
Ethereum
ETH
$1,984.1
-4.37%
Tether USDt
USDT
$0.9999
+0.00%
BNB
BNB
$630.64
-2.77%
XRP
XRP
$1.36
-3.45%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$85.24
-4.02%
TRON
TRX
$0.2849
+0.76%
Dogecoin
DOGE
$0.09084
-3.31%
Cardano
ADA
$0.2587
-4.00%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now